Annual Report by a Canadian Issuer — Form 40-F — SEA’34
Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: 40-F Annual Report by a Canadian Issuer HTML 767K
2: EX-99.1 Miscellaneous Exhibit HTML 46K
3: EX-99.2 Miscellaneous Exhibit HTML 46K
4: EX-99.3 Miscellaneous Exhibit HTML 43K
5: EX-99.4 Miscellaneous Exhibit HTML 43K
6: EX-99.5 Miscellaneous Exhibit HTML 3.32M
7: EX-99.6 Miscellaneous Exhibit HTML 919K
8: EX-99.7 Miscellaneous Exhibit HTML 283K
9: EX-99.8 Miscellaneous Exhibit HTML 43K
15: R1 Cover HTML 100K
16: R2 Audit Information HTML 47K
17: R3 Consolidated Statements of Financial Position HTML 148K
18: R4 Consolidated Statements of Comprehensive Loss HTML 199K
19: R5 Consolidated Statements of Changes in Equity HTML 118K
20: R6 Consolidated Statements of Changes in Equity HTML 48K
(Parenthetical)
21: R7 Consolidated Statements of Cash Flows HTML 140K
22: R8 Nature of Operations HTML 48K
23: R9 Significant Accounting Policies and Judgments HTML 71K
24: R10 Restructuring Provision HTML 69K
25: R11 Accounts Receivable HTML 55K
26: R12 Government Grant HTML 47K
27: R13 Investments HTML 70K
28: R14 Marketable Securities and Derivatives HTML 146K
29: R15 Investments in Associates and Joint Ventures HTML 74K
30: R16 Biological Assets HTML 55K
31: R17 Inventory HTML 77K
32: R18 Property, Plant and Equipment HTML 137K
33: R19 Assets and Liabilities Held for Sale and HTML 118K
Discontinued Operations
34: R20 Business Combinations HTML 68K
35: R21 Asset Acquisition and Non-controlling Interest HTML 51K
(?Nci?)
36: R22 Intangible Assets and Goodwill HTML 172K
37: R23 Convertible Debentures HTML 66K
38: R24 Share Capital HTML 99K
39: R25 Share-Based Compensation HTML 124K
40: R26 Loss Per Share HTML 54K
41: R27 Other Gains (Losses) HTML 60K
42: R28 Supplemental Cash Flow Information HTML 61K
43: R29 Income Taxes HTML 153K
44: R30 Related Party Transactions HTML 69K
45: R31 Commitments and Contingencies HTML 69K
46: R32 Revenue HTML 66K
47: R33 Segmented Information HTML 80K
48: R34 Fair Value of Financial Instruments HTML 116K
49: R35 Financial Instruments Risk HTML 88K
50: R36 Capital Management HTML 46K
51: R37 Subsequent Events HTML 46K
52: R38 Lease Liabilities HTML 62K
53: R39 Significant Accounting Policies and Judgments HTML 273K
(Policies)
54: R40 Significant Accounting Policies and Judgments HTML 52K
(Tables)
55: R41 Restructuring Provision (Tables) HTML 49K
56: R42 Accounts Receivable (Tables) HTML 52K
57: R43 Marketable Securities and Derivatives (Tables) HTML 145K
58: R44 Investments in Associates and Joint Ventures HTML 98K
(Tables)
59: R45 Biological Assets (Tables) HTML 97K
60: R46 Inventory (Tables) HTML 73K
61: R47 Property, Plant and Equipment (Tables) HTML 117K
62: R48 Assets and Liabilities Held for Sale and HTML 102K
Discontinued Operations (Tables)
63: R49 Business Combinations (Tables) HTML 59K
64: R50 Asset Acquisition and Non-controlling Interest HTML 47K
(?Nci?) (Tables)
65: R51 Intangible Assets and Goodwill (Tables) HTML 171K
66: R52 Convertible Debentures (Tables) HTML 57K
67: R53 Share Capital (Tables) HTML 91K
68: R54 Share-Based Compensation (Tables) HTML 118K
69: R55 (Loss) Earnings Per Share (Tables) HTML 52K
70: R56 Other Gains (Losses) (Tables) HTML 60K
71: R57 Supplemental Cash Flow Information (Tables) HTML 62K
72: R58 Income Taxes (Tables) HTML 150K
73: R59 Related Party Transactions (Tables) HTML 67K
74: R60 Commitments and Contingencies (Tables) HTML 47K
75: R61 Revenue (Tables) HTML 58K
76: R62 Segmented Information (Tables) HTML 77K
77: R63 Fair Value of Financial Instruments (Tables) HTML 158K
78: R64 Financial Instruments Risk (Tables) HTML 81K
79: R65 Lease Liabilities (Tables) HTML 57K
80: R66 Significant Accounting Policies and Judgments - HTML 63K
Major Subsidiaries Over Which the Company Has
Control (Details)
81: R67 Restructuring Provision - Narrative (Details) HTML 51K
82: R68 Restructuring Provision - Rollforward of HTML 49K
Restructuring Provision (Details)
83: R69 Accounts Receivable (Details) HTML 56K
84: R70 Government Grant (Details) HTML 56K
85: R71 Investments - Choom Holdings Inc. (Details) HTML 123K
86: R72 Investments - Australis Capital Inc. (Details) HTML 71K
87: R73 Investments - Radient Technologies Inc. (Details) HTML 54K
88: R74 Investments - Cann Group Limited (Details) HTML 75K
89: R75 Investments - Capcium, Inc. (Details) HTML 81K
90: R76 Investments - Investee - B (Details) HTML 92K
91: R77 Investments - High Tide Inc. (Details) HTML 155K
92: R78 Investments - Investee C (Details) HTML 64K
93: R79 Marketable Securities and Derivatives - Marketable HTML 103K
Securities (Details)
94: R80 Marketable Securities and Derivatives - Derivative HTML 107K
Investments (Details)
95: R81 Investments in Associates and Joint Ventures - HTML 77K
Summary of Carrying Value (Details)
96: R82 Biological Assets - Significant Unobservable HTML 61K
Assumptions Used in the Valuation of Biological
Assets, Including Sensitivities (Details)
97: R83 Biological Assets - Changes in Carrying Value of HTML 58K
Biological Assets (Details)
98: R84 Biological Assets - Narrative (Details) HTML 56K
99: R85 Inventory (Details) HTML 89K
100: R86 Property, Plant and Equipment - Narrative HTML 100K
(Details)
101: R87 Property, Plant and Equipment - Carrying Values of HTML 171K
Property, Plant and Equipment (Details)
102: R88 Assets and Liabilities Held for Sale and HTML 108K
Discontinued Operations - Assets Held For Sale
(Details)
103: R89 Assets and Liabilities Held for Sale and HTML 142K
Discontinued Operations - Narrative (Details)
104: R90 Assets and Liabilities Held for Sale and HTML 68K
Discontinued Operations - Discontinued Operations
(Details)
105: R91 Business Combinations - Narrative (Details) HTML 71K
106: R92 Business Combinations - Business Combinations HTML 99K
Completed (Details)
107: R93 Asset Acquisition and Non-controlling Interest HTML 57K
(?NCI?) - Net Change in Non-Controlling Interests
(Details)
108: R94 Asset Acquisition and Non-controlling Interest HTML 66K
(?NCI?) - Narrative (Details)
109: R95 Intangible Assets and Goodwill - Useful Lives HTML 54K
(Details)
110: R96 Intangible Assets and Goodwill - Continuity HTML 104K
Schedule of Intangible Assets and Goodwill
(Details)
111: R97 Intangible Assets and Goodwill - Changes in Net HTML 104K
Book Value of Intangible Assets and Goodwill
(Details)
112: R98 Intangible Assets and Goodwill - Narrative HTML 104K
(Details)
113: R99 Intangible Assets and Goodwill - Key Assumptions HTML 95K
Used in Impairment Testing (Details)
114: R100 Convertible Debentures - Activity of Convertible HTML 62K
Debentures (Details)
115: R101 Convertible Debentures - Narrative (Details) HTML 124K
116: R102 Share Capital - Narrative (Details) HTML 140K
117: R103 Share capital - Summary of Shares Issued for HTML 53K
Equity Financing (Details)
118: R104 Share Capital - Share Purchase Warrants (Details) HTML 44K
119: R105 Share Capital - Summary of Warrant Derivative HTML 57K
Liabilities (Details)
120: R106 Share Capital - Summary of Warrants Outstanding HTML 64K
(Details)
121: R107 Share-Based Compensation - Narrative (Details) HTML 80K
122: R108 Share-Based Compensation - Summary of Options HTML 71K
Outstanding (Details)
123: R109 Share-Based Compensation - Stock Options that HTML 78K
Remain Outstanding, by Exercise Price Range
(Details)
124: R110 Share-Based Compensation - Weighted Average HTML 53K
Assumptions of Options (Details)
125: R111 Share-Based Compensation - Summary of RSUs and HTML 76K
DSUs Outstanding (Details)
126: R112 Share-Based Compensation - RSUs and DSUs that HTML 65K
Remain Outstanding (Details)
127: R113 Share-Based Compensation - Summary of PSUs HTML 66K
Outstanding (Details)
128: R114 Share-Based Compensation - PSUs that Remain HTML 65K
Outstanding (Details)
129: R115 Share-Based Compensation - Weighted Average HTML 56K
Assumptions of PSUs (Details)
130: R116 (Loss) Earnings Per Share (Details) HTML 76K
131: R117 Other Gains (Losses) (Details) HTML 70K
132: R118 Supplemental Cash Flow Information - Changes in HTML 62K
Non-Cash Working Capital (Details)
133: R119 Supplemental Cash Flow Information - Supplementary HTML 54K
Cash Flow Information (Details)
134: R120 Supplemental Cash Flow Information - Narrative HTML 49K
(Details)
135: R121 Income Taxes - Narrative (Details) HTML 49K
136: R122 Income Taxes - Reconciliation of Net Tax Provision HTML 71K
to Income (Loss) Before Income Tax (Details)
137: R123 Income Taxes - Movements in Deferred Tax Assets HTML 130K
(Liabilities) (Details)
138: R124 Income Taxes - Deferred Tax Assets (Liabilities) HTML 50K
(Details)
139: R125 Income Taxes - Deferred Tax Assets Not Recognized HTML 72K
(Details)
140: R126 Related Party Transactions - Compensation Expense HTML 54K
(Details)
141: R127 Related Party Transactions - Transactions with HTML 44K
Related Parties (Details)
142: R128 Related Party Transactions - Receivable from HTML 74K
(Payable to) Related Parties (Details)
143: R129 Commitments and Contingencies - Narrative HTML 66K
(Details)
144: R130 Commitments and Contingencies - Future Commitments HTML 50K
Including Minimum Royalty Payments Due in the Next
Five Years (Details)
145: R131 Revenue - Narrative (Details) HTML 46K
146: R132 Revenue - Revenue from the Transfer of Goods and HTML 64K
Services (Details)
147: R133 Segmented Information - Operating Segments HTML 64K
(Details)
148: R134 Segmented Information - Geographical Segments HTML 57K
(Details)
149: R135 Segmented Information - Narrative (Details) HTML 53K
150: R136 Fair Value of Financial Instruments - Carrying HTML 144K
Values of Financial Instruments (Details)
151: R137 Fair Value of Financial Instruments - Summary of HTML 79K
Financial Instruments Measured at Fair Value
(Details)
152: R138 Fair Value of Financial Instruments - Continuity HTML 70K
Schedule of Contingent Consideration Payable
(Details)
153: R139 Fair Value of Financial Instruments - Narrative HTML 57K
(Details)
154: R140 Financial Instruments Risk - Credit Risk Narrative HTML 50K
(Details)
155: R141 Financial Instruments Risk - Schedule of Aging of HTML 51K
Receivables (Details)
156: R142 Financial Instruments Risk - Schedule of HTML 67K
Contractual Cash Flows from Lease Receivables
(Details)
157: R143 Financial Instruments Risk - Schedule of Accounts HTML 57K
Payable and Accrued Liabilities (Details)
158: R144 Financial Instruments Risk - Liquidity Risk HTML 51K
Narrative (Details)
159: R145 Financial Instruments Risk - Market Risk Narrative HTML 64K
(Details)
160: R146 Capital Management (Details) HTML 44K
161: R147 Subsequent Events (Details) HTML 47K
162: R148 Lease Liabilities - Lease Liabilities (Details) HTML 59K
163: R149 Lease Liabilities - Narrative (Details) HTML 44K
164: R9999 Uncategorized Items - _IXDS HTML 96K
167: XML IDEA XML File -- Filing Summary XML 318K
165: XML XBRL Instance -- acb-20220630_htm XML 6.98M
166: EXCEL IDEA Workbook of Financial Reports XLSX 407K
11: EX-101.CAL XBRL Calculations -- acb-20220630_cal XML 361K
12: EX-101.DEF XBRL Definitions -- acb-20220630_def XML 1.94M
13: EX-101.LAB XBRL Labels -- acb-20220630_lab XML 3.95M
14: EX-101.PRE XBRL Presentations -- acb-20220630_pre XML 2.64M
10: EX-101.SCH XBRL Schema -- acb-20220630 XSD 576K
168: JSON XBRL Instance as JSON Data -- MetaLinks 732± 1.14M
169: ZIP XBRL Zipped Folder -- 0001683541-22-000002-xbrl Zip 1.26M
In connection with the Annual Report of Aurora Cannabis Inc. (the “Company”) on Form 40-F for the period ended June 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Miguel Martin, Chief Executive Officer of the
Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Miguel Martin Chief Executive Officer (Principal Executive Officer)
A signed original of this written statement required by Section 906 has been provided to Aurora Cannabis Inc. and will be retained by Aurora Cannabis Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Dates Referenced Herein and Documents Incorporated by Reference
